Frank E Harrell Jr wrote:
Cody,
How amazing that SAS is still used to produce reports that reviewers
hate and that requires tedious low-level programming. R + LaTeX has it
all over that approach IMHO. We have used that combination very
successfully for several data and safety monitoring reporting tasks for
clinical trials for the pharmaceutical industry.
Frank
There is a point to it, though. One of my friends and colleagues in the
business put it in one word: Mediocrity.
SAS does a mediocre job at analysing and reporting and data handling
using a mediocre control language. But: It can be handled by mediocre
programmers writing and modifying mediocre programs, and those people
are more available and replaceable, maybe even cheaper. R/LaTeX may run
circles around SAS in terms of capapilities, flexibility, and elegance,
but it can also send a programmer who doesn't have the required skill
set running around in circles.
-pd
Cody Hamilton wrote:
Dear all,
There have been a variety of discussions on the R list regarding the
use of R in clinical trials. The following post from the STATA list
provides an interesting opinion regarding why SAS remains so popular
in this arena:
http://www.stata.com/statalist/archive/2008-01/msg00098.html
Regards,
-Cody Hamilton
--
O__ ---- Peter Dalgaard Øster Farimagsgade 5, Entr.B
c/ /'_ --- Dept. of Biostatistics PO Box 2099, 1014 Cph. K
(*) \(*) -- University of Copenhagen Denmark Ph: (+45) 35327918
~~~~~~~~~~ - (p.dalga...@biostat.ku.dk) FAX: (+45) 35327907
______________________________________________
R-help@r-project.org mailing list
https://stat.ethz.ch/mailman/listinfo/r-help
PLEASE do read the posting guide http://www.R-project.org/posting-guide.html
and provide commented, minimal, self-contained, reproducible code.
